Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FGFR2 |
| Variant | exon 5 del |
| Impact List | deletion |
| Protein Effect | unknown |
| Gene Variant Descriptions | FGFR2 exon 5 deletions are in-frame deletions within the extracellular domain of the Fgfr2 protein (PMID: 33926920). |
| Associated Drug Resistance | |
| Category Variants Paths |
FGFR2 mutant FGFR2 exon5 FGFR2 exon 5 del |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06302621 | Phase I | Afatinib + Pemigatinib | Pemigatinib + Afatinib in Advanced Refractory Solid Tumors | Recruiting | USA | 0 |